Search results
Results From The WOW.Com Content Network
The Ayre spatula is a device used to collect Pap smear. It is a wooden spatula with U-shaped openings on one side and a flat surface on another. [1] The broad end is for vaginal sample collection and the narrow end is for cervical sample collection. It is rotated 360 degrees in the vagina to obtain the cells to be sent for Pap smear examination.
An ectocervical biopsy brush used in place of punch forceps during colposcopy to collect a full transepithelial tissue sample. The resulting sample is then sent to a pathology lab for evaluation and diagnosis of cervical cancer.
The Bethesda system (TBS), officially called The Bethesda System for Reporting Cervical Cytology, is a system for reporting cervical or vaginal cytologic diagnoses, [1] used for reporting Pap smear results. It was introduced in 1988 [2] and revised in 1991, [3] 2001, [1] [4] [5] and 2014. [6]
The CPT code revisions in 2013 were part of a periodic five-year review of codes. Some psychotherapy codes changed numbers, for example 90806 changed to 90834 for individual psychotherapy of a similar duration. Add-on codes were created for the complexity of communication about procedures.
Medicare Part B covers the costs of HPV testing. It provides coverage once every 5 years for people between the ages of 30 and 65 years without HPV symptoms.The HPV test is part of the Pap test ...
The Papanicolaou test (abbreviated as Pap test, also known as Pap smear (AE), [1] cervical smear (BE), cervical screening (BE), [2] or smear test (BE)) is a method of cervical screening used to detect potentially precancerous and cancerous processes in the cervix (opening of the uterus or womb) or, more rarely, anus (in both men and women). [3]
Papanicolaou stain (also Papanicolaou's stain and Pap stain) is a multichromatic (multicolored) cytological staining technique developed by George Papanicolaou in 1942. [ 1 ] [ 2 ] [ 3 ] The Papanicolaou stain is one of the most widely used stains in cytology , [ 1 ] where it is used to aid pathologists in making a diagnosis.
However, it is acceptable to screen this age group with a Pap smear alone every 3 years or with an FDA-approved primary high risk HPV test every 5 years. [11] In women over the age of 65, screening for cervical cancer may be discontinued in the absence of abnormal screening results within the prior 10 years and no history of high-grade lesions ...